444 related articles for article (PubMed ID: 34069782)
1. Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice.
Oliveira SR; Dionísio PA; Gaspar MM; Ferreira MBT; Rodrigues CAB; Pereira RG; Estevão MS; Perry MJ; Moreira R; Afonso CAM; Amaral JD; Rodrigues CMP
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069782
[TBL] [Abstract][Full Text] [Related]
2. RIP1/RIP3/MLKL mediates dopaminergic neuron necroptosis in a mouse model of Parkinson disease.
Lin QS; Chen P; Wang WX; Lin CC; Zhou Y; Yu LH; Lin YX; Xu YF; Kang DZ
Lab Invest; 2020 Mar; 100(3):503-511. PubMed ID: 31506635
[TBL] [Abstract][Full Text] [Related]
3. Ablation of RIP3 protects from dopaminergic neurodegeneration in experimental Parkinson's disease.
Dionísio PA; Oliveira SR; Gaspar MM; Gama MJ; Castro-Caldas M; Amaral JD; Rodrigues CMP
Cell Death Dis; 2019 Nov; 10(11):840. PubMed ID: 31690718
[TBL] [Abstract][Full Text] [Related]
4. The Neuroprotective Effects of GPR4 Inhibition through the Attenuation of Caspase Mediated Apoptotic Cell Death in an MPTP Induced Mouse Model of Parkinson's Disease.
Haque ME; Azam S; Akther M; Cho DY; Kim IS; Choi DK
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925146
[TBL] [Abstract][Full Text] [Related]
5. miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson's disease.
Hu YB; Zhang YF; Wang H; Ren RJ; Cui HL; Huang WY; Cheng Q; Chen HZ; Wang G
Cell Death Dis; 2019 Aug; 10(8):589. PubMed ID: 31383850
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
Pariyar R; Bastola T; Lee DH; Seo J
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
[TBL] [Abstract][Full Text] [Related]
7. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.
Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW
Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
9. Whether the Subacute MPTP-Treated Mouse is as Suitable as a Classic Model of Parkinsonism.
Qi Y; Zhang Z; Li Y; Zhao G; Huang J; Zhang Y; Xue J; Tang X
Neuromolecular Med; 2023 Sep; 25(3):360-374. PubMed ID: 36913134
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic neuronal death via necroptosis in Parkinson's disease: A review of the literature.
Regoni M; Valtorta F; Sassone J
Eur J Neurosci; 2024 Mar; 59(6):1079-1098. PubMed ID: 37667848
[TBL] [Abstract][Full Text] [Related]
11. Loss of Microglial Parkin Inhibits Necroptosis and Contributes to Neuroinflammation.
Dionísio PEA; Oliveira SR; Amaral JSJD; Rodrigues CMP
Mol Neurobiol; 2019 Apr; 56(4):2990-3004. PubMed ID: 30074231
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic neuron-specific deletion of p53 gene is neuroprotective in an experimental Parkinson's disease model.
Qi X; Davis B; Chiang YH; Filichia E; Barnett A; Greig NH; Hoffer B; Luo Y
J Neurochem; 2016 Sep; 138(5):746-57. PubMed ID: 27317935
[TBL] [Abstract][Full Text] [Related]
13. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
[TBL] [Abstract][Full Text] [Related]
14. Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model.
Rai SN; Yadav SK; Singh D; Singh SP
J Chem Neuroanat; 2016 Jan; 71():41-9. PubMed ID: 26686287
[TBL] [Abstract][Full Text] [Related]
15. Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease.
González H; Contreras F; Prado C; Elgueta D; Franz D; Bernales S; Pacheco R
J Immunol; 2013 May; 190(10):5048-56. PubMed ID: 23589621
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress and regulated cell death in Parkinson's disease.
Dionísio PA; Amaral JD; Rodrigues CMP
Ageing Res Rev; 2021 May; 67():101263. PubMed ID: 33540042
[TBL] [Abstract][Full Text] [Related]
17. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
[TBL] [Abstract][Full Text] [Related]
18. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
19. The necroptosis machinery mediates axonal degeneration in a model of Parkinson disease.
Oñate M; Catenaccio A; Salvadores N; Saquel C; Martinez A; Moreno-Gonzalez I; Gamez N; Soto P; Soto C; Hetz C; Court FA
Cell Death Differ; 2020 Apr; 27(4):1169-1185. PubMed ID: 31591470
[TBL] [Abstract][Full Text] [Related]
20. Sigma-1 receptor deficiency reduces MPTP-induced parkinsonism and death of dopaminergic neurons.
Hong J; Sha S; Zhou L; Wang C; Yin J; Chen L
Cell Death Dis; 2015 Jul; 6(7):e1832. PubMed ID: 26203861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
